Hosted on MSN1mon
Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn
US private equity firm Bain Capital has agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit Mitsubishi Tanabe Pharma in a deal valued at approximately Y510bn ($3.3bn). The ...
Japan’s Seven & i sells retail business to Bain Capital for $5.4 billion, plans IPO
Japan's Seven & I, the parent company of the Japanese 7-Eleven convenience store chain, says it is selling its supermarket ...
FiercePharma28d
Fierce Pharma Asia—Astellas' investment focus; Mitsubishi Tanabe's buyout; Leqembi's 'expansion phase'
Mitsubishi Tanabe Pharma is being sold to Bain Capital for about $3.3 billion. Eisai expects a Leqembi "expansion phase" on the horizon. And more. 1. Astellas shifts investment focus to later ...
The Financial Times18d
Bain Capital, Chemring and the big-bang theory of M&A leaks
Bain Capital’s reported move is interestingly timed for several reasons. First, Chemring has an AGM trading update on Wednesday. Second, the stock had been strong of late on the realisation that ...
Nikkei Asia25d
Bain Capital withdraws from battle with KKR for Japan's Fuji Soft
TOKYO -- U.S. private equity firm Bain Capital on Monday withdrew its planned bid to take over Japan's Fuji Soft, ending a battle to acquire the systems developer that had been raging with rival ...